Article: The Value of Serbia's Pharmaceuticals and Healthcare Market Is Expected to Top RSD113.77 US$1.69bn in 2013.

Research and Markets (http://www.researchandmarkets.com/research/0b4072/serbia_pharmaceuti) has announced the addition of the "Serbia Pharmaceuticals and Healthcare Report Q4 2009" report to their offering (see also Research and Markets).

This Serbia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Serbia's pharmaceuticals and healthcare industry

In the Q409 Business Environment Rating (BER) matrix, Serbia continued to improve its placement, and is now found in 9th ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!